Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App
Success
Alert
Please select a Day.
Info

Jagsonpal Pharmaceuticals Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs
xpert
Have a query? Talk to Experts LIVE

69/100
185.00
-6.94 (-3.62%)

As on 20 Apr, 2026 | 02:52

Open Trading A/c
Day Range
185.00
194.49
L H
52 Week Range
155.00
301.65
L H
Volume
408,120
*
i

* BSE Market Depth (20 Apr 2026)

BUY SELL
QTY PRICE PRICE QTY
194 185.00 185.15 125
100 184.90 185.20 271
227 184.70 185.30 1
4 184.60 185.50 378
535 184.55 185.55 157
13150 Total Total 19857
Bid / Ask
185.00 / 185.15
69/100
185.00
-7.25 (-3.77%)

As on 20 Apr, 2026 | 02:52

Open Trading A/c
Day Range
185.00
192.90
L H
52 Week Range
154.90
301.80
L H
Volume
12,454
*
i

* BSE Market Depth (20 Apr 2026)

BUY SELL
QTY PRICE PRICE QTY
194 185.00 185.15 125
100 184.90 185.20 271
227 184.70 185.30 1
4 184.60 185.50 378
535 184.55 185.55 157
13150 Total Total 19857
Bid / Ask
185.00 / 185.15
NSE
MC Essentials
59% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Superior Financial Strength, Average Growth Trend Stock Priced at High Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 194.49
          Previous Close 191.94
          Volume 408,120.00
          Value (Lacs) 755.02
            VWAP 187.49
          Beta
          Mkt Cap (Rs. Cr.) 1,242
          High 194.49
          Low 185.00
          UC Limit 230.32
          LC Limit 153.56
          52 Week High 301.65
          52 Week Low 155.00
          Face Value 2.00
          All Time High 328.04
          All Time Low 2.40
          20D Avg Volume 129,285
          20D Avg Delivery(%) 60.28
          Book Value Per Share --
          Dividend Yield 1.35
          TTM EPS See historical trend 0.00 (-22.74% YoY)
          TTM PE See historical trend -- (Average PE)
          P/B See historical trend 0.00 (Low P/B)
          Sector PE 39.94

          Advanced Chart

          Click here to expand
          xpert

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          69/100
          Superior Financial Strength, Average Growth Trend Stock Priced at High Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 38.44% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Above Median

          Shareholding Pattern
          • Promoters decreased holding from 67.54% to 67.39% in Dec 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          16 out of 18 years Jagsonpal Pharmaceuticals has given positive returns in April.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          April 61.25% (2020) 17.25% -5.15% (2019) -4.05% 14.89%

          Forum

          Community Sentiments

          • 0% BUY
          • 0% SELL
          • 100% HOLD
          100%
          of moneycontrol users recommend holding JagsonpalPharma

          What's your call on JagsonpalPharma today?

          Read 0 investor views

          BUY SELL HOLD

          Broker Research

          No Data For Broker Research.

          Deals

          13 Sep, 2024

          Infinity Portfolio Holdings

          Qty 2200000 Price 400 % Traded 8.04
          13 Sep, 2024

          Infinity Holdings

          Qty 2200000 Price 400 % Traded 8.04

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          28 Jul, 2025

          Graviton Research Capital Llp

          Qty 498300 Price 293.68 % Traded 0.74
          28 Jul, 2025

          Graviton Research Capital Llp

          Qty 498300 Price 294.1 % Traded 0.75
          28 Jul, 2025

          Hrti Private Limited

          Qty 350647 Price 293.56 % Traded 0.52
          28 Jul, 2025

          Hrti Private Limited

          Qty 343628 Price 293.5 % Traded 0.51
          29 Nov, 2024

          Ankita Vishal Shah

          Qty 249425 Price 775.17 % Traded 0.95
          29 Nov, 2024

          Ankita Vishal Shah

          Qty 154425 Price 779.54 % Traded 0.59
          13 Sep, 2024

          Infinity Portfolio Holdings

          Qty 2200000 Price 400 % Traded 8.04
          13 Sep, 2024

          Infinity Holdings

          Qty 2200000 Price 400 % Traded 8.04

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          28 Jul, 2025

          graviton research capital llp

          Qty 498,300 Price 294.10 % Traded 0.00
          28 Jul, 2025

          graviton research capital llp

          Qty 498,300 Price 293.68 % Traded 0.00
          28 Jul, 2025

          hrti private limited

          Qty 350,647 Price 293.56 % Traded 0.00
          28 Jul, 2025

          hrti private limited

          Qty 343,628 Price 293.50 % Traded 0.00
          29 Nov, 2024

          ankita vishal shah

          Qty 249,425 Price 775.17 % Traded 0.00
          29 Nov, 2024

          ankita vishal shah

          Qty 154,425 Price 779.54 % Traded 0.00
          13 Sep, 2024

          infinity holdings

          Qty 2,200,000 Price 400.00 % Traded 0.00
          13 Sep, 2024

          infinity portfolio holdings

          Qty 2,200,000 Price 400.00 % Traded 0.00

          Financials

          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Shareholding

          About the Company

          Jagsonpal Pharmaceuticals Limited is engaged in developing and manufacturing active pharmaceutical ingredients (APIs) and formulations. The Company has research and development, manufacturing, marketing and distribution facilities. The Companys plant is located in Uttarakhand. The Companys brands include Lycored, Maintane, Metadec, Metabol, Doxypal DR, Parvon and Indocap SR. Its API products include Allylestrenol, Dextropropoxyphene Hydrochloride, Dextropropoxyphene Napsylate, Disulfiram, Thiopental Sodium, Thiopental Acid and Tolnaftate. The Company operates in Russia, Brazil, the United States, Ukraine, Sri Lanka, Cameroon, Thailand, Argentina, Germany, Switzerland, Korea, Egypt and Vietnam. It was founded in 1964..The company also engagged in the business of Pharmaceutical, Profit Before Tax, Net Profit After Tax.
          {"success":1,"data":{"address":{"address1":"Innov8 3rd Floor,","address2":",Plot No. 211, Okhla Phase \u2013 III,","city":"New Delhi","state":"Delhi","pincode":"110020","telephone1":"011-46181100","telephone2":"011-46119900","fax1":"011-26498341","fax2":"","email":"cs@jagsonpal.com","web":"http:\/\/www.jagsonpal.com"},"management":[{"name":"Rajpal Singh Kochhar","designation":"Chairman Emeritus"},{"name":"Harsha Raghavan","designation":"Chairman & Non-Exe.Director"},{"name":"Manish Gupta","designation":"Managing Director"},{"name":"Prithipal Singh Kochhar","designation":"Non Executive Director"},{"name":"Debasis Bikash Nandy","designation":"Independent Director"}],"registrars":{"name":"MCS Share Transfer Agent Ltd.","address1":"179-180, DSIDC Shed, 3rd Floor, Okhla Industrial A","address2":"","address3":"","address4":"","telephone":"011-41406149, 41406150, 41406151","fax":"011-41709881","email":"helpdeskdelhi@mcsregistrars.com","internet":"www.mcsregistrars.com","city":"New Delhi","state":"Delhi","pincode":"110020"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"507789","nseId":"JAGSNPHARM","series":"EQ","isinid":"INE048B01035"}}}
          • Registered Office

            • Address

              Innov8 3rd Floor,,,Plot No. 211, Okhla Phase – III,

            • City

              New Delhi

            • State

              Delhi

            • Pin Code

              110020

            • Tel. No.

              011-46181100

            • Fax No.

              011-26498341

            • Email

              cs@jagsonpal.com

            • Internet

              http://www.jagsonpal.com

          • Registrars

          • Management

            • Rajpal Singh Kochhar

              Chairman Emeritus

            • Harsha Raghavan

              Chairman & Non-Exe.Director

            • Manish Gupta

              Managing Director

            • Prithipal Singh Kochhar

              Non Executive Director

            • Debasis Bikash Nandy

              Independent Director

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

            • Nifty 200

              No

          • Details

            • BSE:

              507789

            • NSE:

              JAGSNPHARM

            • Series

              EQ

            • ISIN

              INE048B01035

          Advisory Alert:

          It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347